178 related articles for article (PubMed ID: 19472178)
1. Unraveling the mysteries of endostatin.
Fu Y; Tang H; Huang Y; Song N; Luo Y
IUBMB Life; 2009 Jun; 61(6):613-26. PubMed ID: 19472178
[TBL] [Abstract][Full Text] [Related]
2. The N-terminal integrity is critical for the stability and biological functions of endostatin.
Fu Y; Luo Y
Biochemistry; 2010 Aug; 49(30):6420-9. PubMed ID: 20545324
[TBL] [Abstract][Full Text] [Related]
3. Structural analysis of the N-terminal fragment of the antiangiogenic protein endostatin: a molecular dynamics study.
Torres PH; Sousa GL; Pascutti PG
Proteins; 2011 Sep; 79(9):2684-92. PubMed ID: 21769939
[TBL] [Abstract][Full Text] [Related]
4. Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases.
Heljasvaara R; Nyberg P; Luostarinen J; Parikka M; Heikkilä P; Rehn M; Sorsa T; Salo T; Pihlajaniemi T
Exp Cell Res; 2005 Jul; 307(2):292-304. PubMed ID: 15950618
[TBL] [Abstract][Full Text] [Related]
5. Contributions of Zn(II)-binding to the structural stability of endostatin.
Han Q; Fu Y; Zhou H; He Y; Luo Y
FEBS Lett; 2007 Jun; 581(16):3027-32. PubMed ID: 17544408
[TBL] [Abstract][Full Text] [Related]
6. N-terminal fragment of the anti-angiogenic human endostatin binds copper(II) with very high affinity.
Kolozsi A; Jancsó A; Nagy NV; Gajda T
J Inorg Biochem; 2009 Jul; 103(7):940-7. PubMed ID: 19447499
[TBL] [Abstract][Full Text] [Related]
7. Determination of the disulfide bond pattern of the endogenous and recombinant angiogenesis inhibitor endostatin by mass spectrometry.
John H; Forssmann WG
Rapid Commun Mass Spectrom; 2001; 15(14):1222-8. PubMed ID: 11445906
[TBL] [Abstract][Full Text] [Related]
8. Binding of endostatin to phosphatidylserine-containing membranes and formation of amyloid-like fibers.
Zhao H; Jutila A; Nurminen T; Wickström SA; Keski-Oja J; Kinnunen PK
Biochemistry; 2005 Mar; 44(8):2857-63. PubMed ID: 15723529
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action.
Folkman J
Exp Cell Res; 2006 Mar; 312(5):594-607. PubMed ID: 16376330
[TBL] [Abstract][Full Text] [Related]
10. Endostatin signaling and regulation of endothelial cell-matrix interactions.
Wickström SA; Alitalo K; Keski-Oja J
Adv Cancer Res; 2005; 94():197-229. PubMed ID: 16096002
[TBL] [Abstract][Full Text] [Related]
11. High-level synthesis of recombinant murine endostatin in Chinese hamster ovary cells.
Chura-Chambi RM; Tornieri PH; Spencer PJ; Nascimento PA; Mathor MB; Morganti L
Protein Expr Purif; 2004 May; 35(1):11-6. PubMed ID: 15039060
[TBL] [Abstract][Full Text] [Related]
12. Endostatin's heparan sulfate-binding site is essential for inhibition of angiogenesis and enhances in situ binding to capillary-like structures in bone explants.
Gaetzner S; Deckers MM; Stahl S; Löwik C; Olsen BR; Felbor U
Matrix Biol; 2005 Jan; 23(8):557-61. PubMed ID: 15694132
[TBL] [Abstract][Full Text] [Related]
13. Endostatin: the logic of antiangiogenic therapy.
Abdollahi A; Hlatky L; Huber PE
Drug Resist Updat; 2005; 8(1-2):59-74. PubMed ID: 15939343
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic efficacy of recombinant human endostatin combined with chemotherapeutics in mice-transplanted tumors.
Zhu LP; Xing J; Wang QX; Kou L; Li C; Hu B; Wu ZW; Wang JJ; Xu GX
Eur J Pharmacol; 2009 Sep; 617(1-3):23-7. PubMed ID: 19615993
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of recombinant human endostatin in patients with advanced neuroendocrine tumors.
Kulke MH; Bergsland EK; Ryan DP; Enzinger PC; Lynch TJ; Zhu AX; Meyerhardt JA; Heymach JV; Fogler WE; Sidor C; Michelini A; Kinsella K; Venook AP; Fuchs CS
J Clin Oncol; 2006 Aug; 24(22):3555-61. PubMed ID: 16877721
[TBL] [Abstract][Full Text] [Related]
16. Endostatin phenylalanines 31 and 34 define a receptor binding site.
Stahl S; Gaetzner S; Mueller TD; Felbor U
Genes Cells; 2005 Sep; 10(9):929-39. PubMed ID: 16115201
[TBL] [Abstract][Full Text] [Related]
17. Soluble multimer of recombinant endostatin expressed in E. coli has anti-angiogenesis activity.
Wei DM; Gao Y; Cao XR; Zhu NC; Liang JF; Xie WP; Zhen MY; Zhu MS
Biochem Biophys Res Commun; 2006 Jul; 345(4):1398-404. PubMed ID: 16723120
[TBL] [Abstract][Full Text] [Related]
18. Endostatin derivative angiogenesis inhibitors.
Zheng MJ
Chin Med J (Engl); 2009 Aug; 122(16):1947-51. PubMed ID: 19781376
[TBL] [Abstract][Full Text] [Related]
19. Endostatin promotes the anabolic program of rabbit chondrocyte.
Feng Y; Wu YP; Zhu XD; Zhang YH; Ma QJ
Cell Res; 2005 Mar; 15(3):201-6. PubMed ID: 15780183
[TBL] [Abstract][Full Text] [Related]
20. The effect of intracellular protein delivery on the anti-tumor activity of recombinant human endostatin.
Lim J; Duong T; Lee G; Seong BL; El-Rifai W; Ruley HE; Jo D
Biomaterials; 2013 Aug; 34(26):6261-71. PubMed ID: 23714245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
